Greenlight Capital Re, Ltd. Liquidation Value

GLRE presents a positive liquidation posture relative to book value at March 31, 2026, driven primarily by the high liquidity and marketability of its dominant asset — the $515.2M investment in Solasglas (70.3% of total investments), which is carried at NAV and reported as 96.4% Level 1 (actively traded markets). Under a liquidation lens, this asset warrants a meaningful but non-zero haircut given it is a fund interest, not direct securities ownership, and redemptions would face notice periods and potential market impact. A conservative 10-15% haircut on the Solasglas position alone would reduce recoverable value by $52-77M.

The balance sheet shows total assets of $2.27B against total liabilities of $1.53B, yielding reported equity of $741.2M. The dominant liability is the loss and LAE reserve of $966.3M (face value maintained in liquidation). This reserve includes $719.3M in IBNR, which carries high estimation uncertainty, particularly given disclosed adverse development trends in the Financial line (Transactional Liability, 2021 and 2023 underwriting years) and Commercial Auto (Multiline). Any reserve strengthening in liquidation would directly reduce equity recovery.

Reinsurance balances receivable of $672.5M (net) are the second-largest asset class. These are predominantly premiums receivable and funds held at Lloyd's syndicates. Collectability risk is moderate; a 5-10% haircut is reasonable given the mix of ceding counterparties and treaty-based timing uncertainties. Restricted cash of $535.2M is held in trust accounts and letters of credit structures supporting cedents — this cash is operationally encumbered and not freely available; recovery depends on claims run-off dynamics, so it is not equivalent to unrestricted cash at face value in liquidation.

Debt is de minimis at $4.7M net carrying value ($5.0M principal), due in the 3-5 year bucket. Operating lease obligations total $3.0M. The £45M unsecured Citibank LC facility (not drawn as debt) and the CIBC facilities expanded post-period to $300M total committed capacity are contingent commitments, not balance sheet liabilities, but would accelerate claims payment if drawn.

Compared to the prior annual filing (December 31, 2025), equity increased $33.2M to $741.2M, driven by $35.8M net income. Total investments grew $99.5M to $732.6M primarily through reclassification of restricted cash into fixed maturities. Gross loss reserves declined marginally by $1.6M to $966.3M. The Innovations segment retrocession program increased from 28.5% to 33%, reducing gross liability exposure at the cost of lower net earned premium. The MFFAIS CLV/LLV/OLV of $70.3M is substantially below reported equity of $741M, reflecting the platform's own haircut methodology applied to this asset mix — the primary compression factors being the restricted/encumbered nature of most assets and reserve uncertainty.